Physician
Pathology
Dr. Marshall P. Goren, MD
|
|
Give Review
Marshall Goren practices Pathology. Marshall Goren is a published doctor and has 27 publications published. The lastest was: 'Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.'
Publications
- Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
- Enhancement of methotrexate nephrotoxicity after cisplatin therapy.
- Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
- Two automated procedures for N-acetyl-beta-D-glucosaminidase determination evaluated for detection of drug-induced tubular nephrotoxicity.
- Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein.
- Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexate.
- Reduction of dimesna to mesna by the isolated perfused rat liver.
- Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.
- Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
- Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
- The stability of mesna in beverages and syrup for oral administration.
- Oral mesna: a review.
- Ifosfamide/mesna and hematuria.
- Oral administration of mesna with ifosfamide.
- Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
- False-positive ketone tests: a bedside measure of urinary mesna.
- Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
- Ifosfamide in pediatric malignant solid tumors.
- Mesna excretion and ifosfamide nephrotoxicity in children.
- Cumulative renal tubular damage associated with cisplatin nephrotoxicity.
- Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.
- Toxicity, pharmacokinetics, and in vitro hemodialysis clearance of ifosfamide and metabolites in an anephric pediatric patient with Wilms'' tumor.
- Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.
- Combined intravenous and oral mesna in outpatients treated with ifosfamide.
- Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
- Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
Schools
University of Mi Med Sch
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Karin D. Berg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terrence L. Geiger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gina A. Johnston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard E. McLendon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noel T. Florendo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. A N. Sollee, MD |
|
|
Dr. Frank D. Osborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Royce Joyner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mondira Kundu, MD
This Doctor is OpenDoctor Recommended.
|